Elevai Labs, Inc.
ELAB • NASDAQ
Elevai Labs, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Graydon Bensler, with a market cap of $10.2M.
Market Cap$10.2M
Employees18.0
CEOGraydon Bensler
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
ELA
Elevai Labs, Inc. FAQ
Common questions about Elevai Labs, Inc.
Elevai Labs, Inc. is scheduled to report earnings for Q1 2026 on May 13, 2026.
Elevai Labs, Inc. has approximately 18 employees.